StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)

Close on Nov 17, 2026Market cap $74.58BP/E –Yield –

Takeda Pharmaceutical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Takeda Pharmaceutical's enterprise value was $93.42B on Nov 11, 2026, against $72.34B a year earlier. Over the last 5 years it ranged from $65.20B to $93.78B, with a median of $75.16B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$93.42B+23.0%
2025Dec 31, 2025$75.95B+8.8%
2024Dec 31, 2024$69.78B-3.7%
2023Dec 29, 2023$72.47B-4.5%
2022Dec 30, 2022$75.89B+1.4%
2021Dec 31, 2021$74.87B-25.6%
2020Dec 31, 2020$100.60B-7.1%
2019Dec 31, 2019$108.25B+225.9%
2018Dec 31, 2018$33.22B-21.2%
2017Dec 29, 2017$42.15B–

More Takeda Pharmaceutical figures

See a number that looks wrong?